A detailed history of Valeo Financial Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 9,149 shares of VCEL stock, worth $516,918. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,149
Holding current value
$516,918
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$42.25 - $53.56 $386,545 - $490,020
9,149 New
9,149 $386,000
Q2 2021

Jul 22, 2021

SELL
$47.2 - $67.81 $47 - $67
-1 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$3.65 - $5.98 $3 - $5
1
1 $0

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.